Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Peer W. F. Karmaus, James G. Wagner, Jack R. Harkema, Norbert E. Kaminski & Barbara L. F. Kaplan. (2013) Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice. Journal of Immunotoxicology 10:3, pages 321-328.
Read now
Read now
Articles from other publishers (67)
Nicolás Fernández, Marcello Gian Cappello & Patricia Noemí Quiroga. (2023) An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina. Forensic Science International 349, pages 111762.
Crossref
Crossref
Rimanee Kaur & Farideh A. Javid. (2023) Could cannabinoids provide a new hope for ovarian cancer patients?. Pharmacology Research & Perspectives 11:4.
Crossref
Crossref
Aitor Sainz Martinez, Olga Lanaridi, Kristof Stagel, Heidi Halbwirth, Michael Schnürch & Katharina Bica-Schröder. (2023) Extraction techniques for bioactive compounds of cannabis. Natural Product Reports 40:3, pages 676-717.
Crossref
Crossref
Nicoleta Mirela Blebea, Gabriel Hancu, Robert Alexandru Vlad & Andreea Pricopie. (2023) Applications of Capillary Electrophoresis for the Determination of Cannabinoids in Different Matrices. Molecules 28:2, pages 638.
Crossref
Crossref
Nicoleta Mirela Blebea. (2023) Phytocannabinoids and synthetic cannabinoids – pharmacotherapeutic aspects. Farmacist.ro 1:210, pages 10.
Crossref
Crossref
Erdem Altan, Najaf Ali Folladwand, Rymejsa Gurmani, Ömür Türkü Özşalap, Kübra Duvan Aydemir & Ahmet Ulugöl. (2022) PARTICIPATION OF CANNABINOID RECEPTORS IN ANTIPRURITIC ACTIVITY INDUCED BY SYSTEMIC DIPYRONE IN MICE. TURKISH MEDICAL STUDENT JOURNAL 9:1, pages 20-24.
Crossref
Crossref
Nadire Özenver. 2022. Cannabis/Marijuana for Healthcare. Cannabis/Marijuana for Healthcare
131
154
.
Francesco Patti, Clara Grazia Chisari, Claudio Solaro, Maria Donata Benedetti, Eliana Berra, Assunta Bianco, Roberto Bruno Bossio, Fabio Buttari, Letizia Castelli, Paola Cavalla, Raffaella Cerqua, Gianfranco Costantino, Claudio Gasperini, Angelica Guareschi, Domenico Ippolito, Roberta Lanzillo, Giorgia Teresa Maniscalco, Manuela Matta, Damiano Paolicelli, Loredana Petrucci, Simona Pontecorvo, Isabella Righini, Margherita Russo, Francesco Saccà, Giovanna Salamone, Elisabetta Signoriello, Gabriella Spinicci, Daniele Spitaleri, Eleonora Tavazzi, Maria Trotta, Mauro Zaffaroni & Mario Zappia. (2020) Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study. Neurological Sciences 41:10, pages 2905-2913.
Crossref
Crossref
Clara Grazia Chisari, Claudio Solaro, Pasquale Annunziata, Roberto Bergamaschi, Assunta Bianco, Simona Bonavita, Vincenzo Brescia Morra, Roberto Bruno Bossio, Elisabetta Capello, Letizia Castelli, Paola Cavalla, Gianfranco Costantino, Diego Centonze, Salvatore Cottone, Maura Chiara Danni, Federica Esposito, Alberto Gajofatto, Claudio Gasperini, Angelica Guareschi, Roberta Lanzillo, Giacomo Lus, Giorgia Teresa Maniscalco, Manuela Matta, Damiano Paolicelli, Loredana Petrucci, Simona Pontecorvo, Isabella Righini, Marco Rovaris, Edoardo Sessa, Gabriella Spinicci, Daniele Spitaleri, Paola Valentino, Mauro Zaffaroni, Mario Zappia & Francesco Patti. (2020) Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. Journal of Neurology, Neurosurgery & Psychiatry 91:9, pages 914-920.
Crossref
Crossref
Zaid H. Maayah, Shingo Takahara, Mourad Ferdaoussi & Jason R.B. Dyck. (2020) The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:7, pages 165771.
Crossref
Crossref
Zaid H. Maayah, Shingo Takahara, Mourad Ferdaoussi & Jason R. B. Dyck. (2020) The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis. Inflammation Research 69:6, pages 549-558.
Crossref
Crossref
Elise Wouters, Jolien Walraed, Samuel D. Banister & Christophe P. Stove. (2019) Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists. Biochemical Pharmacology 169, pages 113623.
Crossref
Crossref
Vittoria Borgonetti, Paolo Governa, Monica Montopoli & Marco Biagi. (2019) Cannabis sativa L. Constituents and Their Role in Neuroinflammation. Current Bioactive Compounds 15:2, pages 147-158.
Crossref
Crossref
Antonella Ciaramella. 2019. Psychopharmacology of Neurologic Disease. Psychopharmacology of Neurologic Disease
317
337
.
Thomas M. Attard, Camille Bainier, Marine Reinaud, Alexandra Lanot, Simon J. McQueen-Mason & Andrew J. Hunt. (2018) Utilisation of supercritical fluids for the effective extraction of waxes and Cannabidiol (CBD) from hemp wastes. Industrial Crops and Products 112, pages 38-46.
Crossref
Crossref
Sidarta Ribeiro. 2018. Plant Medicines, Healing and Psychedelic Science. Plant Medicines, Healing and Psychedelic Science
133
149
.
Tristan A. Reekie, Michael P. Scott & Michael Kassiou. (2017) The evolving science of phytocannabinoids. Nature Reviews Chemistry 2:1.
Crossref
Crossref
Sabrina Giacoppo, Placido Bramanti & Emanuela Mazzon. (2017) Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation. Multiple Sclerosis and Related Disorders 17, pages 22-31.
Crossref
Crossref
Fabiana Piscitelli, Ester Pagano, Anna Lauritano, Angelo A. Izzo & Vincenzo Di Marzo. (2017)
Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ
9
-Tetrahydrocannabivarin, and Cannabigerol in Mouse Peripheral Tissues
. Analytical Chemistry 89:8, pages 4749-4755.
Crossref
Crossref
Susan R.B. Weiss, Katia D. Howlett & Ruben D. Baler. (2017) Building smart cannabis policy from the science up. International Journal of Drug Policy 42, pages 39-49.
Crossref
Crossref
Sara Valdeolivas, Onintza Sagredo, Mercedes Delgado, Miguel Pozo & Javier Fernández-Ruiz. (2017) Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington’s Disease. International Journal of Molecular Sciences 18:4, pages 684.
Crossref
Crossref
Ethan B. Russo & Jahan Marcu. 2017. Cannabinoid Pharmacology. Cannabinoid Pharmacology
67
134
.
Bruno Brochet, Christine Lebrun-Frénay, Jérôme de Sèze, Hélène Zéphir, E. Allart, B. Audoin, X. Ayrignac, C. Bensa, A. Blanchard-Dauphin, D. Brassat, C. Carra-Dallière, P. Clavelou, M. Cohen, A. Créange, N. Collongues, M. Debouverie, G. Defer, M. de Sèze, C. Donzé, G. Edan, A. Fromont, X. Gamé, O. Gout, C. Guillon, C. Harand, B. Jenny, P. Labauge, P.-H. Lalive, E. Le Page, P. Marque, L. Michel, X. Moisset, J.-C. Ouallet, O. Outteryck, F. Pelé, J. Pelletier, S. Pittion-Vouyovitch, A.-L. Ramelli, A. Ruet, E. Thouvenot, D. Veillard, C. Vignal-Clermont & S. Vukusic. 2017. La Sclérose en Plaques - Clinique et Thérapeutique. La Sclérose en Plaques - Clinique et Thérapeutique
3
78
.
Wen-Juan Huang, Wei-Wei Chen & Xia Zhang. (2016) Endocannabinoid system: Role in depression, reward and pain control (Review). Molecular Medicine Reports 14:4, pages 2899-2903.
Crossref
Crossref
Alberto Gajofatto. (2016) Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis. Multiple Sclerosis and Related Disorders 8, pages 64-65.
Crossref
Crossref
Javier Carreras, Mariia S. Kirillova & Antonio M. Echavarren. (2016) Synthesis of (−)-Cannabimovone and Structural Reassignment of Anhydrocannabimovone through Gold(I)-Catalyzed Cycloisomerization. Angewandte Chemie International Edition 55:25, pages 7121-7125.
Crossref
Crossref
Javier Carreras, Mariia S. Kirillova & Antonio M. Echavarren. (2016) Synthesis of (−)-Cannabimovone and Structural Reassignment of Anhydrocannabimovone through Gold(I)-Catalyzed Cycloisomerization. Angewandte Chemie 128:25, pages 7237-7241.
Crossref
Crossref
Omar Abdel-Salam. (2016) Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids. Asian Pacific Journal of Tropical Medicine 9:5, pages 413-419.
Crossref
Crossref
Carla Marinelli, Thomas Bertalot, Morena Zusso, Stephen D. Skaper & Pietro Giusti. (2016) Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage. Frontiers in Cellular Neuroscience 10.
Crossref
Crossref
Uwe K. Zettl, Paulus Rommer, Petra Hipp & Robert Patejdl. (2015) Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis. Therapeutic Advances in Neurological Disorders 9:1, pages 9-30.
Crossref
Crossref
Brian F. Thomas & Mahmoud A. ElSohly. 2016. The Analytical Chemistry of Cannabis. The Analytical Chemistry of Cannabis
111
115
.
Jahan P. Marcu. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
672
678
.
Patrycja Kleczkowska, Irena Smaga, Małgorzata Filip & Magdalena Bujalska-Zadrozny. (2015) Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug?. Neurotoxicity Research 29:1, pages 173-196.
Crossref
Crossref
Francesco Scaglione. (2015) How to Choose the Right Serenoa repens Extract. European Urology Supplements 14:9, pages e1464-e1469.
Crossref
Crossref
Orrin Devinsky, Benjamin J. Whalley & Vincenzo Di Marzo. (2015) Cannabinoids in the Treatment of Neurological Disorders. Neurotherapeutics 12:4, pages 689-691.
Crossref
Crossref
A Feliú, M Moreno-Martet, M Mecha, F J Carrillo-Salinas, E de Lago, J Fernández-Ruiz & C Guaza. (2015)
A Sativex
®
-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
. British Journal of Pharmacology 172:14, pages 3579-3595.
Crossref
Crossref
Venkatesh L. Hegde, Udai P. Singh, Prakash S. Nagarkatti & Mitzi Nagarkatti. (2015) Critical Role of Mast Cells and Peroxisome Proliferator–Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo. The Journal of Immunology 194:11, pages 5211-5222.
Crossref
Crossref
Katja Schmitz, Julia Barthelmes, Leonie Stolz, Susanne Beyer, Olaf Diehl & Irmgard Tegeder. (2015) “Disease modifying nutricals” for multiple sclerosis. Pharmacology & Therapeutics 148, pages 85-113.
Crossref
Crossref
Seth Ammerman, Sheryl Ryan, William P. Adelman, Sharon Levy, Seth D. Ammerman, Pamela K. Gonzalez, Sheryl A. Ryan, Lorena M. Siqueira, Vincent C. Smith, Paula K. Braverman, William P. Adelman, Elizabeth Meller Alderman, Cora C. Breuner, David A. Levine, Arik V. Marcell & Rebecca Flynn O’Brien. (2015) The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update. Pediatrics 135:3, pages e769-e785.
Crossref
Crossref
Omar M. E. Abdel-Salam, Eman R. Youness, Yasser Ashry Khadrawy, Nadia A. Mohammed, Rehab Fawzy Abdel-Rahman, Enayat A. Omara & Amany A. Sleem. (2014) The effect of cannabis on oxidative stress and neurodegeneration induced by intrastriatal rotenone injection in rats. Comparative Clinical Pathology 24:2, pages 359-378.
Crossref
Crossref
M. Freidel, K. Tiel-Wilck, H. Schreiber, A. Prechtl, U. Essner & M. Lang. (2015)
Drug-resistant MS spasticity treatment with Sativex
®
add-on and driving ability
. Acta Neurologica Scandinavica 131:1, pages 9-16.
Crossref
Crossref
Vincenzo Di Marzo & Jenny W. Wang. 2015. The Endocannabinoidome. The Endocannabinoidome
xiii
xvii
.
Sara Valdeolivas, Carmen Navarrete, Irene Cantarero, María L. Bellido, Eduardo Muñoz & Onintza Sagredo. (2014) Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice. Neurotherapeutics 12:1, pages 185-199.
Crossref
Crossref
Ana Bagüés, M. Isabel Martín & Eva M. Sánchez-Robles. (2014) Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain. European Journal of Pharmacology 745, pages 69-75.
Crossref
Crossref
Michelle Sexton, Eiron Cudaback, Rehab A. Abdullah, John Finnell, Laurie K. Mischley, Mary Rozga, Aron H. Lichtman & Nephi Stella. (2014) Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters. Inflammopharmacology 22:5, pages 295-303.
Crossref
Crossref
Miguel Moreno-Martet, Francisco Espejo-Porras, Javier Fernández-Ruiz & Eva de Lago. (2014)
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1
G93A
Transgenic Mice and Evaluation of a Sativex
®
-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis
. CNS Neuroscience & Therapeutics 20:9, pages 809-815.
Crossref
Crossref
Omar M. E. Abdel-Salam, Enayat A. Omara, Marawa El-Sayed El-Shamarka & Jihan Seid Hussein. (2013) Nigrostriatal damage after systemic rotenone and/or lipopolysaccharide and the effect of cannabis. Comparative Clinical Pathology 23:5, pages 1343-1358.
Crossref
Crossref
Omar M. E. Abdel-Salam, Somaia A. Nada, Neveen A. Salem, Marawa El-Sayed El-Shamarka & Enayat Omara. (2013) Effect of Cannabis sativa on oxidative stress and organ damage after systemic endotoxin administration in mice. Comparative Clinical Pathology 23:4, pages 1069-1085.
Crossref
Crossref
L. Lorente Fernández, E. Monte Boquet, F. Pérez-Miralles, I. Gil Gómez, M. Escutia Roig, I. Boscá Blasco, J.L. Poveda Andrés & B. Casanova-Estruch. (2014) Clinical experiences with cannabinoids in spasticity management in multiple sclerosis. Neurología (English Edition) 29:5, pages 257-260.
Crossref
Crossref
L. Lorente Fernández, E. Monte Boquet, F. Pérez-Miralles, I. Gil Gómez, M. Escutia Roig, I. Boscá Blasco, J.L. Poveda Andrés & B. Casanova-Estruch. (2014) Experiencia clínica con los cannabinoides en la terapia de la espasticidad en la esclerosis múltiple. Neurología 29:5, pages 257-260.
Crossref
Crossref
Omar M. E. Abdel-Salam, Marwa El-Sayed El-Shamarka, Nermeen Shaffee & Alaa El-Din M. Gaafar. (2012) Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide. Comparative Clinical Pathology 23:3, pages 495-507.
Crossref
Crossref
Jürgen Koehler. (2014) Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience. European Neurology 71:Suppl. 1, pages 10-15.
Crossref
Crossref
Ahmed Toosy, Olga Ciccarelli & Alan Thompson. 2014. Multiple Sclerosis and Related Disorders. Multiple Sclerosis and Related Disorders
513
562
.
Francisco Espejo-Porras, Javier Fernández-Ruiz, Roger G. Pertwee, Raphael Mechoulam & Concepción García. (2013) Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors. Neuropharmacology 75, pages 155-163.
Crossref
Crossref
Katarzyna Starowicz & Vincenzo Di Marzo. (2013) Non-psychotropic analgesic drugs from the endocannabinoid system: “Magic bullet” or “multiple-target” strategies?. European Journal of Pharmacology 716:1-3, pages 41-53.
Crossref
Crossref
Slava Rom & Yuri Persidsky. (2013) Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation. Journal of Neuroimmune Pharmacology 8:3, pages 608-620.
Crossref
Crossref
M. I. Vicente-Valor, P. Garcia-Llopis, L. Mejia Andujar, G. Antonino de la Camara, N. García del Busto, M. J. Lopez Tinoco, B. Quintana Vergara, C. Peiro Vilaplana, J. A. Dominguez Moran & A. Sánchez Alcaraz. (2013) Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report. Journal of Clinical Pharmacy and Therapeutics 38:1, pages 71-73.
Crossref
Crossref
Javier Fernández-Ruiz, Onintza Sagredo, M. Ruth Pazos, Concepción García, Roger Pertwee, Raphael Mechoulam & José Martínez-Orgado. (2013) Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?. British Journal of Clinical Pharmacology 75:2, pages 323-333.
Crossref
Crossref
Alan M. Palmer. (2013) Multiple Sclerosis and the Blood-Central Nervous System Barrier. Cardiovascular Psychiatry and Neurology 2013, pages 1-10.
Crossref
Crossref
Willy Pedersen & Sveinung Sandberg. (2012) The medicalisation of revolt: a sociological analysis of medical cannabis users. Sociology of Health & Illness 35:1, pages 17-32.
Crossref
Crossref
E. Ma Sánchez Robles, A. Bagües Arias & Ma I. Martín Fontelles. (2012) Cannabinoids and muscular pain. Effectiveness of the local administration in rat. European Journal of Pain 16:8, pages 1116-1127.
Crossref
Crossref
A. Hilliard, C. Stott, S. Wright, G. Guy, G. Pryce, S. Al-Izki, C. Bolton & G. Giovannoni. (2012) Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis. ISRN Neurology 2012, pages 1-7.
Crossref
Crossref
M Mecha, A S Torrao, L Mestre, F J Carrillo-Salinas, R Mechoulam & C Guaza. (2012) Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress. Cell Death & Disease 3:6, pages e331-e331.
Crossref
Crossref
Sara Valdeolivas, Valentina Satta, Roger G. Pertwee, Javier Fernández-Ruiz & Onintza Sagredo. (2012)
Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB
1
and CB
2
Receptors
. ACS Chemical Neuroscience 3:5, pages 400-406.
Crossref
Crossref
Kirsten Schulte, Nina Steingrüber, Bernd Jergas, Agnes Redmer, Christina Maria Kurz, Rainer Buchalla, Beat Lutz, Andreas Zimmer & Eberhard Schlicker. (2012) Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor. Naunyn-Schmiedeberg's Archives of Pharmacology 385:4, pages 385-396.
Crossref
Crossref
Alan M. Palmer. (2012) Pharmacotherapeuetic Options for the Treatment of Multiple Sclerosis. Clinical Medicine Insights: Therapeutics 4, pages CMT.S8661.
Crossref
Crossref
Maria Grazia Cascio & Roger Pertwee. 2011. Marijuana and Madness. Marijuana and Madness
23
34
.